112 related articles for article (PubMed ID: 3559551)
1. Platinum(IV) chloride complexes with heterocyclic ligands.
Massacesi M; Pinna R; Ponticelli G; Puggioni G
J Inorg Biochem; 1987 Feb; 29(2):95-100. PubMed ID: 3559551
[TBL] [Abstract][Full Text] [Related]
2. Unsymmetrical C-substituted ethylenediamine platinum coordination complexes: synthesis and activity against mouse leukemia L1210.
Hall LM; Speer RJ; Ridgway HJ; Norton SJ
J Inorg Biochem; 1979 Oct; 11(2):139-49. PubMed ID: 501351
[TBL] [Abstract][Full Text] [Related]
3. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity.
Lee K; Tashiro T; Noji M
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic, biological, and antitumor studies on N-ethyl- and N-propylimidazole platinum(II) complexes.
Ponticelli G; Biddau M; Zakharova IA; Tatjanenko LV
J Inorg Biochem; 1987 Feb; 29(2):101-9. PubMed ID: 2951494
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligands.
Khokhar AR; Deng Y; Kido Y; Siddik ZH
J Inorg Biochem; 1993 May; 50(2):79-87. PubMed ID: 8487040
[TBL] [Abstract][Full Text] [Related]
6. Chemical and biological studies on a series of lipid-soluble (trans-(R,R)- and -(S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes.
Khokhar AR; al-Baker S; Brown T; Perez-Soler R
J Med Chem; 1991 Jan; 34(1):325-9. PubMed ID: 1992134
[TBL] [Abstract][Full Text] [Related]
7. Relationships between reduction properties and cancer cell growth inhibitory activities of cis-dichloro- and cis-diiodo-Pt(IV)-ethylenediamines.
Kratochwil NA; Bednarski PJ
Arch Pharm (Weinheim); 1999 Aug; 332(8):279-85. PubMed ID: 10489538
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2].
Shamsuddin S; Santillan CC; Stark JL; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 1998 Aug; 71(1-2):29-35. PubMed ID: 9755489
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of 1,2-diaminocyclohexane platinum(IV) complexes.
Khokhar AR; al-Baker S; Siddik ZH
J Inorg Biochem; 1994 Apr; 54(1):39-47. PubMed ID: 8151310
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
12. Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane.
Vollano JF; Al-Baker S; Dabrowiak JC; Schurig JE
J Med Chem; 1987 Apr; 30(4):716-9. PubMed ID: 3560163
[TBL] [Abstract][Full Text] [Related]
13. Activity of platinum(II) intercalating agents against murine leukemia L1210.
McFadyen WD; Wakelin LP; Roos IA; Leopold VA
J Med Chem; 1985 Aug; 28(8):1113-6. PubMed ID: 4020833
[TBL] [Abstract][Full Text] [Related]
14. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and anti-tumour testing of some platinum(II) amine complexes containing 1,1- and 1,2-cyclobutanedicarboxylate ligands.
Hill WE; McAuliffe CA; Sharma HL; Zaki A
Chem Biol Interact; 1990; 73(2-3):337-51. PubMed ID: 2155716
[TBL] [Abstract][Full Text] [Related]
16. Platinum complexes of substituted ethylenediamines and their anti-tumour activity.
Beaumont KP; McAuliffe CA; Cleare MJ
Chem Biol Interact; 1976 Jul; 14(1-2):179-93. PubMed ID: 954137
[TBL] [Abstract][Full Text] [Related]
17. Platinum(II) complexes of 4-methoxy- and 4-chlorobenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect.
Dodoff N; Grancharov K; Spassovska N
J Inorg Biochem; 1995 Dec; 60(4):257-66. PubMed ID: 8530921
[TBL] [Abstract][Full Text] [Related]
18. Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2- phenylethylenediamine](sulfato)platinum-(II) complexes with variable substituents in the 2-phenyl ring. 1. Synthesis and antitumor and estrogenic properties.
Gust R; Burgemeister T; Mannschreck A; Schönenberger H
J Med Chem; 1990 Sep; 33(9):2535-44. PubMed ID: 2391694
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
[TBL] [Abstract][Full Text] [Related]
20. New platinum (II) and platinum (IV) complexes with 1,2-diaminocyclohexane. Synthesis and in vitro and in vivo antitumour evaluation.
Craciunescu DG; Furlani Candiani A; Scarcia V; Doadrio A; Ghirvu C
J Pharm Belg; 1985; 40(2):79-84. PubMed ID: 4009393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
